Cargando…
Inhaled nitric oxide as a rescue therapy in a preterm neonate with severe pulmonary hypertension: a case report
BACKGROUND: Inhaled nitric oxide (iNO) has been approved for the treatment of persistent pulmonary hypertension of the newborn (PPHN) in term and near-term newborns. Its role in the management of persistent pulmonary hypertension in preterm infants is not clear. Although guidelines do not exist, som...
Autores principales: | Busè, Martina, Graziano, Francesco, Lunetta, Fabio, Sulliotti, Giorgio, Duca, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952598/ https://www.ncbi.nlm.nih.gov/pubmed/29764471 http://dx.doi.org/10.1186/s13052-018-0494-9 |
Ejemplares similares
-
Inhaled Nitric Oxide Use in Preterm Infants in California Neonatal Intensive Care Units
por: Handley, Sara C., et al.
Publicado: (2016) -
Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response
por: Nelin, Leif D., et al.
Publicado: (2019) -
Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension
por: Preston, Ioana R., et al.
Publicado: (2013) -
Clinical response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
por: Ko, S. Y., et al.
Publicado: (1998) -
Inhaled Nitric Oxide before Induction of Anesthesia in Patients with Pulmonary Hypertension
por: Eljezi, Vedat, et al.
Publicado: (2021)